Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study.
Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study. Invest New Drugs. 1994; 12(1):65-6.